Wilson Mark Andrew

Track

Insider profile

Performance

Overall performance
4.0
Performance over holding periods
4.0
30 days 90 days 120 days
Average return 8% 8.2% 15.1%
Success rate 60% 68% 82%
Transactions
24 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Wilson Mark Andrew's trades of Nektar Therapeutics's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-13 2026-03-13
PrS Proposed sale
10,442
476.91
US$1,869,989 		10,442 476.91 US$1,869,989
2025-11-25 2025-11-25
PrS Proposed sale
25,968
262.25
US$2,290,742 		25,968 262.25 US$2,290,742
2025-11-25 2025-11-25
S Sale
55,422 +46.3%
171.65
US$2,734,581 		55,422 +46.3% 171.65 US$2,734,581
2025-08-21 2025-08-19
S Sale
676 -3.2%
26.59
US$17,975 		676 -3.2% 26.59 US$17,975
2025-08-19 2025-08-19
PrS Proposed sale
676
26.59
US$17,975 		676 26.59 US$17,975
2025-05-21 2025-05-19
S Sale
9,996 -3.1%
0.67
US$6,697 		9,996 -3.1% 0.67 US$6,697
2025-05-19 2025-05-19
PrS Proposed sale
9,996
0.67
US$6,710 		9,996 0.67 US$6,710
2025-02-21 2025-02-19
S Sale
11,040 -3.3%
1.01
US$11,150 		11,040 -3.3% 1.01 US$11,150
2025-02-19 2025-02-19
PrS Proposed sale
11,040
1.01
US$11,137 		11,040 1.01 US$11,137
2024-12-26 2024-12-24
PrS Proposed sale
16,560
0.89
US$14,801 		16,560 0.89 US$14,801
2024-12-26 2024-12-24
S Sale
16,560 -4.7%
0.89
US$14,738 		16,560 -4.7% 0.89 US$14,738
2024-12-26 2024-12-23
S Sale
33,402 -8.7%
0.90
US$30,062 		33,402 -8.7% 0.90 US$30,062
2024-12-23 2024-12-23
PrS Proposed sale
33,402
0.90
US$29,898 		33,402 0.90 US$29,898
2024-11-20 2024-11-19
S Sale
6,407 -2.8%
1.01
US$6,471 		6,407 -2.8% 1.01 US$6,471
2024-11-19 2024-11-19
PrS Proposed sale
6,407
1.01
US$6,483 		6,407 1.01 US$6,483
2024-08-20 2024-08-19
S Sale
5,651 -2.4%
1.28
US$7,233 		5,651 -2.4% 1.28 US$7,233
2024-08-19 2024-08-19
PrS Proposed sale
5,651
1.28
US$7,211 		5,651 1.28 US$7,211
2024-05-20 2024-05-17
S Sale
6,260 -2.6%
1.75
US$10,955 		6,260 -2.6% 1.75 US$10,955
2024-05-20 2024-05-17
S Sale
6,260 -2.6%
1.75
US$10,955 		6,260 -2.6% 1.75 US$10,955
2024-05-17 2024-05-17
PrS Proposed sale
6,260
1.75
US$10,980 		6,260 1.75 US$10,980
2024-02-22 2024-02-20
S Sale
7,606 -3.1%
0.68
US$5,172 		7,606 -3.1% 0.68 US$5,172
2024-02-20 2024-02-20
PrS Proposed sale
7,606
0.68
US$5,149 		7,606 0.68 US$5,149
2023-11-20 2023-11-17
S Sale
7,179 -2.9%
0.49
US$3,518 		7,179 -2.9% 0.49 US$3,518
2023-11-17 2023-11-17
PrS Proposed sale
7,179
0.49
US$3,515 		7,179 0.49 US$3,515
2023-08-17 2023-08-16
S Sale
7,221 -2.8%
0.78
US$5,632 		7,221 -2.8% 0.78 US$5,632
2023-05-17 2023-05-16
S Sale
7,543 -2.8%
0.72
US$5,431 		7,543 -2.8% 0.72 US$5,431
2023-02-17 2023-02-16
S Sale
8,275 -3.0%
3.00
US$24,825 		8,275 -3.0% 3.00 US$24,825
2022-11-18 2022-11-16
S Sale
8,690 -3.1%
3.57
US$31,023 		8,690 -3.1% 3.57 US$31,023
2022-08-17 2022-08-16
S Sale
3,189 -1.1%
4.76
US$15,180 		3,189 -1.1% 4.76 US$15,180
2022-05-17 2022-05-16
S Sale
3,136 -2.6%
3.95
US$12,387 		3,136 -2.6% 3.95 US$12,387
2022-02-18 2022-02-16
S Sale
3,661 -2.9%
10.95
US$40,088 		3,661 -2.9% 10.95 US$40,088
2021-11-17 2021-11-16
S Sale
6,564 -7.1%
13.16
US$86,382 		6,564 -7.1% 13.16 US$86,382
2021-05-19 2021-05-17
S Sale
1,917 -2.5%
18.30
US$35,081 		1,917 -2.5% 18.30 US$35,081
2021-02-18 2021-02-16
S Sale
2,173 -2.8%
22.37
US$48,610 		2,173 -2.8% 22.37 US$48,610
2021-02-04 2021-02-03
PlS Planned sale
5,344 -6.3%
19.45
US$103,941 		5,344 -6.3% 19.45 US$103,941
2020-11-18 2020-11-16
S Sale
1,539 -3.0%
16.93
US$26,055 		1,539 -3.0% 16.93 US$26,055
2020-08-19 2020-08-17
S Sale
1,529 -2.9%
19.67
US$30,075 		1,529 -2.9% 19.67 US$30,075
2020-05-20 2020-05-18
S Sale
1,529 -2.8%
22.51
US$34,418 		1,529 -2.8% 22.51 US$34,418